U.S. pharma large copyright scrapped two experimental weight loss tablets very last yr—a after-each day pill, lotiglipron, because of elevated liver enzymes and also a two times-everyday capsule, danuglipron, resulting from powerful Unwanted effects—but CEO Albert Bourla has explaine